AMRI Acquires Whitehouse Laboratories
PTSM: Pharmaceutical Technology Sourcing and Management
AMRI adds analytical capabilities to its outsourcing services offerings with the acquisition of Whitehouse Labs.
Albany Molecular Research Inc. (AMRI) announced on Dec. 15, 2015, that it has acquired all the outstanding equity interests of Whitehouse Laboratories for $54 million in cash, and an additional $2 million in shares of AMRI common stock contingent upon Whitehouse Labs achieving certain 2015 targets.
Whitehouse Labs, based in Lebanon, NJ, offers testing solutions for life sciences including materials and excipients, container qualification and container closure integrity testing, analytical chemistry, drug delivery systems and device qualification programs, packaging, distribution, and stability and storage programs.
In a statement announcing the acquisition, William S. Marth, AMRI's president and chief executive officer noted that Whitehouse Labs’ service offerings meet the needs of its customers and will augment the company’s discovery, development, and manufacturing services.
Source: Albany Molecular Research Inc. (AMRI)
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Entering New Domains for 3D Printing of Drug Products
April 6th 20253D printing of personalized medications is currently possible under existing compounding regulations, offering enhanced process control through automation. But new legislation coming in 2025 will allow 3D printing as part of a distributed manufacturing framework.
